Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating castration resistant prostate cancer and metastasis by reducing B-cell number and/or function

Methods for treating castration resistant prostate cancer and metastasis by reducing B-cell number and/or function

US Patent 9433686 · Granted Sep 6, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination therapy for cancer2025
Methods for treating macrophage-mediated diseases, and methods of identifying ag2025
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions2025
Anti-CXCR5 antibodies and compositions and uses thereof2024
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions2024
Methods for treating NLRP3 inflammasome-associated diseases, and methods of iden2023
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions2022
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions2021
Hepatocytes with high regenerative capacity for liver repair2021
Anti-CXCR5 antibodies and compositions and uses thereof2020
Methods for treating NLRP3 inflammasome-associated diseases, and methods of iden2020
Chemoimmunotherapy for epithelial cancer2020